ContractHeska Corp • August 7th, 2019 • In vitro & in vivo diagnostic substances
Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
AMENDMENT TO ASSET PURCHASE and LICENSE AGREEMENTAsset Purchase and License Agreement • August 7th, 2019 • Heska Corp • In vitro & in vivo diagnostic substances
This AMENDMENT TO ASSET PURCHASE and LICENSE AGREEMENT (this "Amendment") is entered into effective upon the date of last signature (the "Amendment Effective Date"), by and between:
THIRD AMENDMENT TO CREDIT AGREEMENTCredit Agreement • August 7th, 2019 • Heska Corp • In vitro & in vivo diagnostic substances
This Third Amendment to Credit Agreement, dated as of July 16, 2019 (this "Amendment"), is among HESKA CORPORATION, DIAMOND ANIMAL HEALTH, INC. and HESKA IMAGING, LLC (the “Borrowers”), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”).
ContractDiamond Animal • August 7th, 2019 • Heska Corp • In vitro & in vivo diagnostic substances
Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
